BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gwee KA, Goh V, Lima G, Setia S. Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: Risks versus benefits. J Pain Res. 2018;11:361-374. [PMID: 29491719 DOI: 10.2147/jpr.s156938] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Li C, Hu Y, Nie Q, Chen S, Li G, Li L, Chen S, Tang B, Zhang J. A reactive oxygen species-responsive antioxidant nanotherapy for the treatment of drug-induced tissue and organ injury. Biomater Sci 2020;8:7117-31. [PMID: 33211787 DOI: 10.1039/d0bm01660h] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Bruno G, Zaccari P, Rocco G, Scalese G, Panetta C, Porowska B, Pontone S, Severi C. Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified. World J Gastroenterol 2019; 25(22): 2706-2719 [PMID: 31235994 DOI: 10.3748/wjg.v25.i22.2706] [Cited by in CrossRef: 55] [Cited by in F6Publishing: 42] [Article Influence: 18.3] [Reference Citation Analysis]
3 Basak M, Mahata T, Chakraborti S, Kumar P, Bhattacharya B, Bandyopadhyay SK, Das M, Stewart A, Saha S, Maity B. Malabaricone C Attenuates Nonsteroidal Anti-Inflammatory Drug-Induced Gastric Ulceration by Decreasing Oxidative/Nitrative Stress and Inflammation and Promoting Angiogenic Autohealing. Antioxid Redox Signal 2020;32:766-84. [PMID: 31830804 DOI: 10.1089/ars.2019.7781] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kim JH, Shin CY, Jang SW, Kim DS, Lee W, Kim HG, Kim HR. Anti-inflammatory effects of DA-9601, an extract of Artemisia asiatica, on aceclofenac-induced acute enteritis. Korean J Physiol Pharmacol 2021;25:439-48. [PMID: 34448461 DOI: 10.4196/kjpp.2021.25.5.439] [Reference Citation Analysis]
5 Bergamaschi G, Caprioli F, Lenti MV, Elli L, Radaelli F, Rondonotti E, Mengoli C, Miceli E, Ricci C, Ardizzone S, Vecchi M, Di Sabatino A. Pathophysiology and therapeutic management of anemia in gastrointestinal disorders. Expert Rev Gastroenterol Hepatol 2022;:1-13. [PMID: 35696485 DOI: 10.1080/17474124.2022.2089114] [Reference Citation Analysis]
6 Orlova YY, Mehla S, Chua AL. Drug Safety in Episodic Migraine Management in Adults Part 1: Acute Treatments. Curr Pain Headache Rep 2022. [PMID: 35536501 DOI: 10.1007/s11916-022-01057-3] [Reference Citation Analysis]
7 Kaczmar E, Rychlik A, Szweda M. The evaluation of three treatment protocols using oral prednisone and oral meloxicam for therapy of canine idiopathic lymphoplasmacytic rhinitis: a pilot study. Ir Vet J 2018;71:19. [PMID: 30305889 DOI: 10.1186/s13620-018-0131-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
8 Ho KY, Gwee KA, Cheng YK, Yoon KH, Hee HT, Omar AR. Nonsteroidal anti-inflammatory drugs in chronic pain: implications of new data for clinical practice. J Pain Res 2018;11:1937-48. [PMID: 30288088 DOI: 10.2147/JPR.S168188] [Cited by in Crossref: 38] [Cited by in F6Publishing: 12] [Article Influence: 9.5] [Reference Citation Analysis]
9 Mizokami Y, Yamamoto T, Atarashi H, Yamashita T, Akao M, Ikeda T, Koretsune Y, Okumura K, Shimizu W, Tsutsui H, Toyoda K, Hirayama A, Yasaka M, Yamaguchi T, Teramukai S, Kimura T, Kaburagi J, Takita A, Inoue H. Current status of proton pump inhibitor use in Japanese elderly patients with non-valvular atrial fibrillation: A subanalysis of the ANAFIE Registry. PLoS One 2020;15:e0240859. [PMID: 33151969 DOI: 10.1371/journal.pone.0240859] [Reference Citation Analysis]
10 Derwich M, Mitus-Kenig M, Pawlowska E. Orally Administered NSAIDs-General Characteristics and Usage in the Treatment of Temporomandibular Joint Osteoarthritis-A Narrative Review. Pharmaceuticals (Basel) 2021;14:219. [PMID: 33807930 DOI: 10.3390/ph14030219] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Bishop RC, Kemper AM, Wilkins PA, McCoy AM. Effect of omeprazole and sucralfate on gastrointestinal injury in a fasting/NSAID model. Equine Vet J 2021. [PMID: 34719063 DOI: 10.1111/evj.13534] [Reference Citation Analysis]
12 Oncel S, Basson MD. Gut homeostasis, injury, and healing: New therapeutic targets. World J Gastroenterol 2022; 28(17): 1725-1750 [DOI: 10.3748/wjg.v28.i17.1725] [Reference Citation Analysis]
13 Zaghlool SS, Abo-Seif AA, Rabeh MA, Abdelmohsen UR, Messiha BAS. Gastro-Protective and Anti-Oxidant Potential of Althaea officinalis and Solanum nigrum on Pyloric Ligation/Indomethacin-Induced Ulceration in Rats. Antioxidants (Basel) 2019;8:E512. [PMID: 31731465 DOI: 10.3390/antiox8110512] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Chen S, Jiang J, Chao G, Hong X, Cao H, Zhang S. Pure Total Flavonoids From Citrus Protect Against Nonsteroidal Anti-inflammatory Drug-Induced Small Intestine Injury by Promoting Autophagy in vivo and in vitro. Front Pharmacol 2021;12:622744. [PMID: 33953669 DOI: 10.3389/fphar.2021.622744] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Vora P, Herrera R, Pietila A, Mansmann U, Brobert G, Peltonen M, Salomaa V. Risk factors for major gastrointestinal bleeding in the general population in Finland. World J Gastroenterol 2022; 28(18): 2008-2020 [DOI: 10.3748/wjg.v28.i18.2008] [Reference Citation Analysis]
16 Oncel S, Gupta R, Wang Q, Basson MD. ZINC40099027 Promotes Gastric Mucosal Repair in Ongoing Aspirin-Associated Gastric Injury by Activating Focal Adhesion Kinase. Cells 2021;10:908. [PMID: 33920786 DOI: 10.3390/cells10040908] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Setia S, Ryan NJ, Nair PS, Ching E, Subramaniam K. Evolving role of pharmaceutical physicians in medical evidence and education. Adv Med Educ Pract 2018;9:777-90. [PMID: 30464675 DOI: 10.2147/AMEP.S175683] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
18 Akbulut S, Caliskan AR, Saritas H, Demyati K, Bilgic Y, Unsal S, Koc C, Yilmaz S. Analysis of risk factors affecting the development of peptic ulcer perforation: case-control study. Prz Gastroenterol 2021;16:23-8. [PMID: 33986884 DOI: 10.5114/pg.2020.94744] [Reference Citation Analysis]
19 Zhu LP, Zhao JW, Chen X, Wang BM. Proton pump inhibitor usage and nonsteroidal anti-inflammatory drugs-associated small intestinal injury: How to balance risks and benefits. Shijie Huaren Xiaohua Zazhi 2018; 26(22): 1334-1339 [DOI: 10.11569/wcjd.v26.i22.1334] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Bayram D, Aydin V, Sanli A, Abanoz MN, Sibic B, Pala S, Atac O, Akici A. Comparison of paracetamol and diclofenac prescribing preferences for adults in primary care. Prim Health Care Res Dev 2021;22:e78. [PMID: 34852871 DOI: 10.1017/S1463423621000797] [Reference Citation Analysis]
21 Monta A, Redon S, Fabre C, Donnet A. A retrospective observation on 105 patients with chronic cluster headache receiving indomethacin. Neurol Sci 2021;42:4175-82. [PMID: 33547540 DOI: 10.1007/s10072-021-05114-4] [Reference Citation Analysis]
22 Ho KY, Cardosa MS, Chaiamnuay S, Hidayat R, Ho HQT, Kamil O, Mokhtar SA, Nakata K, Navarra SV, Nguyen VH, Pinzon R, Tsuruoka S, Yim HB, Choy E. Practice Advisory on the Appropriate Use of NSAIDs in Primary Care. J Pain Res 2020;13:1925-39. [PMID: 32821151 DOI: 10.2147/JPR.S247781] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Tandoh A, Danquah CA, Benneh CK, Adongo DW, Boakye-gyasi E, Woode E. Effect of Diclofenac and Andrographolide Combination on Carrageenan-Induced Paw Edema and Hyperalgesia in Rats. Dose-Response 2022;20:155932582211038. [DOI: 10.1177/15593258221103846] [Reference Citation Analysis]
24 Cetin H, Sun J, Almqvist C, Reichardt B, Tomschik M, Zimprich F, Fang F, Ingre C. No association between proton pump inhibitor use and ALS risk: a nationwide nested case-control study. Sci Rep 2020;10:13371. [PMID: 32770128 DOI: 10.1038/s41598-020-70373-8] [Reference Citation Analysis]
25 Migliorini F, Asparago G, Oliva F, Cuozzo F, Maffulli N. A comprehensive update on the pharmacological management of heterotopic ossification following hip arthroplasty: a level I evidenced based expert opinion. Expert Opin Pharmacother 2022;:1-9. [PMID: 35698796 DOI: 10.1080/14656566.2022.2088280] [Reference Citation Analysis]
26 Guo CG, Leung WK. Potential Strategies in the Prevention of Nonsteroidal Anti-inflammatory Drugs-Associated Adverse Effects in the Lower Gastrointestinal Tract. Gut Liver 2020;14:179-89. [PMID: 31547642 DOI: 10.5009/gnl19201] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
27 Cadet C, Maheu E; and The French AGRHUM Group (Association Geriatric and RHeUMatology). Non-steroidal anti-inflammatory drugs in the pharmacological management of osteoarthritis in the very old: prescribe or proscribe? Ther Adv Musculoskelet Dis 2021;13:1759720X211022149. [PMID: 34211591 DOI: 10.1177/1759720X211022149] [Reference Citation Analysis]
28 Abd El-hay SS, El Sheikh R, Gouda AA, Ali M, El-sayed HM. Simultaneous estimation of pantoprazole and piroxicam by HPLC: Response surface methodology approach. Microchemical Journal 2022;176:107247. [DOI: 10.1016/j.microc.2022.107247] [Reference Citation Analysis]
29 Fernando GC, Kondasinghe JS. Mechanistic approach to the management of cancer-related nausea and vomiting in a palliative care resource-limited setting. Int J Palliat Nurs 2021;27:362-6. [PMID: 34569286 DOI: 10.12968/ijpn.2021.27.7.362] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Walker C. Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac. Int J Rheumatol 2018;2018:1302835. [PMID: 30631366 DOI: 10.1155/2018/1302835] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
31 Pongratz G. Spezielle Schmerztherapie bei rheumatischen Erkrankungen. Aktuelle Rheumatologie 2020;45:430-42. [DOI: 10.1055/a-1203-5172] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]